454 related articles for article (PubMed ID: 33209019)
1. Effects of Chinese Herbal Medicine on Acute Exacerbations of COPD: A Randomized, Placebo-Controlled Study.
Li J; Zhang H; Ruan H; Si Y; Sun Z; Liu H; Feng J; Wang Y; Li L; Bai L; Sun H
Int J Chron Obstruct Pulmon Dis; 2020; 15():2901-2912. PubMed ID: 33209019
[TBL] [Abstract][Full Text] [Related]
2. Effect of sequential treatment with TCM syndrome differentiation on acute exacerbation of chronic obstructive pulmonary disease and AECOPD risk window.
Jiansheng L; Haifeng W; Suyun L; Hailong Z; Xueqing Y; Xiaoyun Z; Fengsen L; Xianmei Z; Zikai S; Yimin M; Lijun M; Yijie Z; Guojun Z; Bingxiang T
Complement Ther Med; 2016 Dec; 29():109-115. PubMed ID: 27912934
[TBL] [Abstract][Full Text] [Related]
3. Effects of Chinese medicine on patients with acute exacerbations of COPD: study protocol for a randomized controlled trial.
Zhang H; Li J; Yu X; Li S; Wang H; Ruan H; Si Y; Xie Y; Wang M
Trials; 2019 Dec; 20(1):735. PubMed ID: 31842969
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of Xuebijing injection and its influence on immunomodulation in acute exacerbations of chronic obstructive pulmonary disease: study protocol for a randomized controlled trial.
Xie S; Yan P; Yao C; Yan X; Huo Y; Zhang J; Liu S; Feng Z; Shang H; Xie L
Trials; 2019 Feb; 20(1):136. PubMed ID: 30777117
[TBL] [Abstract][Full Text] [Related]
5. Effect of sequential treatment with syndrome differentiation on acute exacerbation of chronic obstructive pulmonary disease and "AECOPD Risk-Window": study protocol for a randomized placebo-controlled trial.
Haifeng W; Jiansheng L; Suyun L; Xueqing Y; Hailong Z; Zhiwan W; Qiyi W; Pankui Z; Zhongchao W; Fenglei L; Haihong Y
Trials; 2012 Apr; 13():40. PubMed ID: 22520863
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of Kangxian Huanji Granule as adjunctive treatment in acute exacerbation of idiopathic pulmonary fibrosis: An exploratory randomized controlled trial.
Li JS; Zhang HL; Guo W; Wang L; Zhang D; Zhao LM; Zhou M
J Integr Med; 2023 Nov; 21(6):543-549. PubMed ID: 37993378
[TBL] [Abstract][Full Text] [Related]
7. Effects of YuPingFeng granules on acute exacerbations of COPD: a randomized, placebo-controlled study.
Ma J; Zheng J; Zhong N; Bai C; Wang H; Du J; Li F; Chen Y; Shi Z; Li X; Chen P
Int J Chron Obstruct Pulmon Dis; 2018; 13():3107-3114. PubMed ID: 30323581
[TBL] [Abstract][Full Text] [Related]
8. Efficiency and Safety of Baofei Granules in Chronic Obstructive Pulmonary Disease (Lung and Spleen Qi Deficiency Syndrome): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial.
Sun Y; Chen X; Zhang L; Yuan WA; Chen Q; Zhang YB; Liu LJ; Zhang W; Sun M
Drug Des Devel Ther; 2022; 16():4251-4267. PubMed ID: 36540716
[TBL] [Abstract][Full Text] [Related]
9. Effects of the Chinese herbal formula San-Huang Gu-Ben Zhi-Ke treatment on stable chronic obstructive pulmonary disease: study protocol of a randomized, double-blind, placebo-controlled trial.
Zu Y; Li D; Lei X; Zhang H
Trials; 2019 Nov; 20(1):647. PubMed ID: 31775843
[TBL] [Abstract][Full Text] [Related]
10. Xuan Bai Cheng Qi formula as an adjuvant treatment of acute exacerbation of chronic obstructive pulmonary disease of the syndrome type phlegm-heat obstructing the lungs: a multicenter, randomized, double-blind, placebo-controlled clinical trial.
Liu M; Zhong X; Li Y; Zheng F; Wu R; Sun Y; Zhang J
BMC Complement Altern Med; 2014 Jul; 14():239. PubMed ID: 25014996
[TBL] [Abstract][Full Text] [Related]
11. Shufeng Jiedu capsule for acute exacerbation of chronic obstructive pulmonary disease: a protocol of multicentre, randomised, double-blind, placebo-controlled trial.
Xia R; Fei Y; Zhang L; Jie Z; Fan X; Dai M; Moore M; Willcox M; Hu X; Francis N; Liang C; Fei G; Liu J
BMJ Open; 2023 Sep; 13(9):e070864. PubMed ID: 37775286
[TBL] [Abstract][Full Text] [Related]
12. Preventive Effects of Qingfei Yihuo Capsules () on Air Pollution Associated Exacerbation of Chronic Obstructive Pulmonary Disease: A Single-blind, Randomized, Controlled Trial.
Hu WP; Wu XD; Li ZZ; Zhang J
Chin J Integr Med; 2020 Nov; 26(11):806-811. PubMed ID: 32876858
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy and safety of Chinese herbal medicine versus placebo for the treatment of chronic obstructive pulmonary disease: A systematic review and meta-analysis.
Xiong C; Li Y; Zhuang G; Zeng Y; Wei H; Li C; Li L; Liao L; Fu J
Complement Ther Med; 2021 Jun; 59():102691. PubMed ID: 33618010
[TBL] [Abstract][Full Text] [Related]
14. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
Ni H; Htet A; Moe S
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
[TBL] [Abstract][Full Text] [Related]
15. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Vollenweider DJ; Jarrett H; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
Cochrane Database Syst Rev; 2012 Dec; 12():CD010257. PubMed ID: 23235687
[TBL] [Abstract][Full Text] [Related]
16. Shufeng Jiedu capsules for treating acute exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Xia RY; Hu XY; Fei YT; Willcox M; Wen LZ; Yu MK; Zhang LS; Dai MY; Fei GH; Thomas M; Francis N; Wilkinson T; Moore M; Liu JP
BMC Complement Med Ther; 2020 May; 20(1):151. PubMed ID: 32448238
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Xin Jia Xuan Bai Cheng Qi Decoction in treating acute exacerbation of chronic obstructive pulmonary disease: study protocol for a multicentre, randomised, controlled trial.
Jin J; Zhang H; Li D; Jing Y; Sun Z; Feng J; Zhang H; Zhang Y; Cui T; Lei X; Zhang J; Cheng Q; Li E
BMJ Open; 2019 Nov; 9(11):e030249. PubMed ID: 31784433
[TBL] [Abstract][Full Text] [Related]
18. Treatment with JianPiYiFei II granules for patients with moderate to very severe chronic obstructive pulmonary disease: A 52-week randomised, double-blinded, placebo-controlled, multicentre trial.
Chen Y; Gong X; Zhou M; Xu Y; Fan F; Xiao J; Liu L; Shi K; Li S; Zhuo J; Chen Z; Yu X; Fan L; Chen Y; Wu L; Lin L
Phytomedicine; 2022 Jun; 100():154057. PubMed ID: 35349835
[TBL] [Abstract][Full Text] [Related]
19. Treating acute exacerbations of COPD with Chinese herbal medicine to aid antibiotic use reduction (Excalibur): a randomised double-blind, placebo-controlled feasibility trial.
Willcox ML; Hu XY; Oliver T; Thorne K; Boxall C; He G; Simpson C; Brotherwood B; O'Neil A; Waugh R; Tilt E; Trill J; Goward N; Francis N; Thomas M; Little P; Wilkinson T; Liu JP; Griffiths G; Moore M
Front Pharmacol; 2023; 14():1221905. PubMed ID: 37818189
[No Abstract] [Full Text] [Related]
20. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
